SCHEMBL20320951

SCHEMBL20320951

C#CCCC(N)(N)CCOc1ccc(C=O)cc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.43
SMN1; SMN2 Q16637 5/20 0.43
LMNA P02545 4/20 0.43
MAPT P10636 3/20 0.43
HPGD P15428 2/20 0.43
KDM4E B2RXH2 4/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CYP2A6 P11509 1/20 0.35
STS P08842 1/20 0.35
RAB9A P51151 1/20 0.35
MAOA P21397 2/20 0.35
MAOB P27338 2/20 0.35
PTGS2 P35354 1/20 0.35
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
PARP10 Q53GL7 1/20 0.33
PARP3 Q9Y6F1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20321107 0.84 MAOA (0.45) ALDH1A1SMN1; SMN2MAPTHPGDKDM4E
SCHEMBL11912907 0.81 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2LMNAMAPTHPGD
SCHEMBL3346351 0.80 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2LMNAMAPTHPGD
Hydrochloric Acid SCHEMBL28530836 0.79 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2LMNAMAPTHPGD
SCHEMBL1232335 0.79 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2LMNAMAPTHPGD
SCHEMBL8926474 0.77 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2LMNAMAPTHPGD
SCHEMBL851166 0.72 ALDH1A1 (0.66) ALDH1A1SMN1; SMN2LMNAMAPTHPGD
SCHEMBL1982503 0.72 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2LMNAMAPTHPGD
SCHEMBL16894536 0.72 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2LMNAMAPTHPGD
SCHEMBL8547015 0.72 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2LMNAMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4306166-A2 COMPOUNDS, COMPOSITIONS AND METHODS OF USE Aquinnah Pharmaceuticals Inc. (US) 2024-01-17 EP disclosed
EP-3557998-B1 COMPOUNS, COMPOSITIONS AND METHODS OF USE AQUINNAH PHARMACEUTICALS INC (US) 2023-08-16 EP disclosed
WO-2018119395-A1 COMPOUNS, COMPOSITIONS AND METHODS OF USE AQUINNAH PHARMACEUTICALS, INC. (US) 2018-06-28 WO disclosed